Who Is Dr. Daniel Labow?
Dr. Daniel Labow is the Chair of Surgical Services at Nuvance Health Praxair Cancer Center in Danbury, Connecticut. Prior to joining the medical team at Nuvance Health, he spent nearly 20 years working as the director of the hyperthermic intraperitoneal chemotherapy (HIPEC) program at Mount Sinai Health System in New York City.
HIPEC, sometimes referred to simply as heated chemotherapy, is one of the most effective treatments for those suffering from peritoneal mesothelioma. Patients who undergo this treatment can often live for 5 years or more.
Dr. Labow championed the use of this treatment at Mount Sinai and, over his long tenure, transformed its cancer center into one of the largest and busiest providers of HIPEC in the United States.
Get the answers about the treatment you need from top specialists with our free guide of Questions to Ask Your Mesothelioma Doctor.
- Finding Top Treatments
- Affording Treatments
- Joining a Clinical Trial
What Does Dr. Labow Treat?
Dr. Daniel M. Labow is one of the nation’s leading experts in the field of mesothelioma treatment — specifically peritoneal mesothelioma.
When treating mesothelioma and other cancers, Dr. Labow often makes use of the HIPEC procedure, in which a concentrated dose of heated chemotherapy is inserted into the body. This method is meant to kill or damage cancer cells while causing as little damage as possible to healthy cells.
Dr. Labow and other doctors typically administer HIPEC after removing all visible mesothelioma tumors from the abdomen using cytoreductive surgery.
Besides peritoneal mesothelioma, Dr. Labow treats other gastrointestinal cancers like bile duct cancer and liver cancer.
Dr. Labow’s Medical Background
Dr. Daniel Labow started his medical education by earning a bachelor’s degree in biology from the University of Pennsylvania in Philadelphia.
He followed this by earning his medical degree from the Warren Alpert Medical School at Brown University, then completing his general surgical residency at the University of Chicago Hospital. Here, he was awarded the title of Administrative Chief Resident.
Dr. Labow continued his training with an additional residency at the New York-Presbyterian Weill Cornell Medical Center.
He joined Mount Sinai Health System in 2004 and remained there before starting his new position with Nuvance Health Praxair Cancer Center in March 2023.
Experience
Dr. Labow has performed over 600 HIPEC procedures on patients with a variety of cancers.
Dr. Labow also trains and educates other surgeons in the field of cancer treatment.
He directs and works on multiple clinical trials for cancer research, attempting to improve current treatment methods and discover new ones that could prolong the lives of cancer patients.
Medical Specializations
While Dr. Labow’s medical knowledge and research contributions are extensive, his main focus has always been in the treatment of various types of cancer, most notably peritoneal mesothelioma.
Dr. Labow specializes in the following treatments:
- HIPEC
- Gastrectomy (removal of all or part of the stomach)
- Radiofrequency ablation (using radio waves to shrink cancerous tumors)
- Splenectomy (removal of the spleen)
- Other surgical techniques
Dr. Labow’s Treatment Approach
Dr. Labow believes that treatment and prevention are integral components of the healing process for cancer patients.
In this sense, he often approaches patient care by combining different treatments to produce the most desirable results. Treatments utilized by Dr. Labow for mesothelioma include surgery for mesothelioma, HIPEC, and more.
Patients say Dr. Labow is trustworthy, explains conditions well, and has easy scheduling.
Looking to find the best mesothelioma doctors to treat you? We can help. Contact us to get started.
Highlights of Dr. Labow’s Medical Career
Dr. Labow is an award-winning and highly accomplished surgical oncologist and cancer treatment specialist.
Awards and Accolades
Throughout his career as a general surgeon and gastrointestinal cancer expert, Dr. Labow has received both local and national recognition.
Some of his awards and accolades include:
- Named as a top doctor by Castle Connolly (2010-present)
- Named one of New York Magazine’s “Best Doctors” (2013-2022)
- Ranked as one of the best doctors in the New York Metro area (2016-2022)
- Received the Robert Paradny Teaching Award in 2007
Work Highlights
Dr. Labow has furthered his contributions to the fields of cancer research and treatment through a number of roles and certifications.
These memberships and roles include:
- Chair member of the Gastrointestinal Disease Focus Group at Mount Sinai Hospital
- Executive Vice Chair and Vice Chair of Quality for Mt. Sinai's Department of Surgery
- Founder and Director of the HIPEC program at Mount Sinai Health System
- Member of the American College of Surgeons
- Member of the American Hepatopancreaticobiliary Association
- Member of the Society of Surgical Oncology Education Committee
- New York State chair member of the Commission on Cancer
- Program Director of Mount Sinai Hospital’s Surgical Oncology Fellowship
Research and Published Works
Dr. Labow frequently participates in and contributes to a variety of research publications on topics such as general surgery and mesothelioma.
Some of his most recent contributions include:
- Carr, J. et al. “African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality.” Published in Journal of Immigrant and Minority Health, April 2022.
- Macfie, R. C., et al. “Hyperthermic intraperitoneal chemotherapy does not increase risk of major complication or failure to rescue in cytoreductive surgery.” Published in Journal of Surgical Oncology, September 2022.
- Pletcher, E., et al. “Postoperative Respiratory Failure Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy is Associated with Volume of Intraoperative Crystalloid Administration and Worse Survival.” Published in Annals of Surgical Oncology, January 2023.
- Shaltiel, T., et al. “Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with improved perioperative outcomes: a single-center early experience propensity-matched analysis.” Published in Surgical Endoscopy and Other Interventional Techniques, August 2022.
Dr. Labow’s Work in Cancer Treatment & Research
Dr. Labow has dedicated much of his professional career to furthering cancer treatment advancements and research.
It is the hope of Dr. Labow and his colleagues to not only prolong the lives of patients but to improve their quality of life after a mesothelioma diagnosis.
Dr. Labow recognizes that while advancements have already been made in these areas, there is still much work to be done.
Some of the medical challenges that Dr. Labow has highlighted throughout his extensive career include diagnostic challenges, problems with inaccurate staging, and the need for improved and more suitable treatments and therapies.
For these reasons, Dr. Labow continues to work toward helping patients and studying better ways to treat peritoneal mesothelioma.
Get in Touch With Dr. Labow
If you or a loved one has been diagnosed with peritoneal mesothelioma, you may be a good candidate for the HIPEC procedure performed by Dr. Labow.
The Mesothelioma Veterans Center can assist you in connecting with Dr. Labow and other top mesothelioma doctors throughout the United States. Our team can also help you get military benefits if you're a veteran and financial compensation.
Get a Free Veterans Packet for more information and to start the process of finding top doctors.
